397 related articles for article (PubMed ID: 3342597)
1. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
[TBL] [Abstract][Full Text] [Related]
2. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
3. Intravenous indomethacin therapy in preterm neonates with patent ductus arteriosus.
Rajadurai VS; Yu VY
J Paediatr Child Health; 1991 Dec; 27(6):370-5. PubMed ID: 1756081
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
Quinn D; Cooper B; Clyman RI
Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
[TBL] [Abstract][Full Text] [Related]
5. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
[TBL] [Abstract][Full Text] [Related]
6. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus.
Keller RL; Clyman RI
Pediatrics; 2003 Sep; 112(3 Pt 1):583-7. PubMed ID: 12949288
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Su PH; Chen JY; Su CM; Huang TC; Lee HS
Pediatr Int; 2003 Dec; 45(6):665-70. PubMed ID: 14651538
[TBL] [Abstract][Full Text] [Related]
8. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.
Hammerman C
Clin Perinatol; 1995 Jun; 22(2):457-79. PubMed ID: 7671547
[TBL] [Abstract][Full Text] [Related]
9. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
Cherif A; Jabnoun S; Khrouf N
Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
[TBL] [Abstract][Full Text] [Related]
11. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
12. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic closure of the ductus arteriosus: benefits and limitations.
Mercanti I; Boubred F; Simeoni U
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic reopening of ductus arteriosus after successful closure by indomethacin in premature infants.
Yen SL; Teng RJ; Ho MM
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(5):379-84. PubMed ID: 8237357
[TBL] [Abstract][Full Text] [Related]
15. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
16. Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants.
Tammela O; Ojala R; Iivainen T; Lautamatti V; Pokela ML; Janas M; Koivisto M; Ikonen S
J Pediatr; 1999 May; 134(5):552-7. PubMed ID: 10228288
[TBL] [Abstract][Full Text] [Related]
17. Combined noninvasive assessment of the patent ductus arteriosus in the preterm infant before and after indomethacin treatment.
Smallhorn JF; Gow R; Olley PM; Freedom RM; Swyer PR; Perlman M; Rowe RD
Am J Cardiol; 1984 Dec; 54(10):1300-4. PubMed ID: 6507302
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants.
Mahony L; Carnero V; Brett C; Heymann MA; Clyman RI
N Engl J Med; 1982 Mar; 306(9):506-10. PubMed ID: 7035955
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
